within Pharmacolibrary.Drugs.G_GenitoUrinarySystemAndSexHormones.G03A_HormonalContraceptivesForSystemicUse.G03AD02_Ulipristal;

model Ulipristal
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_2C_enteral(
    weight = 70,
    F = 0.63,
    Cl = 1.7194444444444445e-05,
    adminDuration = 600,
    adminMass = 30 / 1000000,
    adminCount = 1,
    Vd = 0.36,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.007,
    Tlag = 10.200000000000001,
    Vdp = 0.144,
    k12 = 2.625e-05,
    k21 = 2.625e-05);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Ulipristal</td></tr><tr><td>ATC code:</td><td>G03AD02</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>2</td></tr>
    <tr><td>dosage:</td><td>30</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>360</td><td>L</td></tr>
    <tr><td>clearance:</td><td>61.9</td><td>L/h</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Ulipristal acetate is a selective progesterone receptor modulator used primarily as an emergency contraceptive and in some countries for management of uterine fibroids. It is approved for short-term use for these indications.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters described for healthy adult female volunteers after a single oral administration of ulipristal acetate 30 mg for emergency contraception.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.G.G03AD02 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Ulipristal;
